123
Views
7
CrossRef citations to date
0
Altmetric
Review

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability

, , , , , , , , & show all
Pages 105-111 | Published online: 28 Jul 2016

References

  • ParisiRSymmonsDPGriffithsCEAshcroftDMIdentification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalenceJ Invest Dermatol2013133237738523014338
  • RachakondaTDSchuppCWArmstrongAWPsoriasis prevalence among adults in the United StatesJ Am Acad Dermatol201470351251624388724
  • FeldmanSRMalakoutiMKooJYSocial impact of the burden of psoriasis: effects on patients and practiceDermatol Online J2014208
  • LebwohlMGKavanaughAArmstrongAWVan VoorheesASUS perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) surveyAm J Clin Dermatol2016171879726718712
  • KruegerGKooJLebwohlMMenterASternRSRolstadTThe impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership surveyArch Dermatol2001137328028411255325
  • LegatFJHoferAWackernagelANarrowband UV-B phototherapy, alefacept, and clearance of psoriasisArch Dermatol200714381016102217709660
  • LevinECGuptaRBrownGMalakoutiMKooJBiologic fatigue in psoriasisJ Dermatolog Treat2014251788223875537
  • LebwohlMMenterAKooJFeldmanSRCombination therapy to treat moderate to severe psoriasisJ Am Acad Dermatol200450341643014988684
  • De SimoneCD’AgostinoMCapizziRCapponiAVenierACaldarolaGCombined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasisEur J Dermatol201121456857221697032
  • KircikLBagelJKormanNUtilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomesJ Drugs Dermatol20087324525318380206
  • WolfPHoferALegatFJTreatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanerceptBr J Dermatol2009160118618919067710
  • LyndeCWGuptaAKGuentherLPoulinYLevesqueABissonnetteRA randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanerceptJ Dermatolog Treat201223426126721797805
  • GambichlerTTiggesCScolaNEtanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeksBr J Dermatol201116461383138621466532
  • Calzavara-PintonPGSalaRArisiMRossiMTVenturiniMOrtelBSynergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasisBr J Dermatol2013169113013623834117
  • WolfPHoferAWegerWPosch-FabianTGruber-WackernagelALegatFJ311 nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patientsPhotodermatol Photoimmunol Photomed201127418618921729166
  • BagelJAdalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasisJ Drugs Dermatol201110436637121455546
  • WolfPWegerWLegatFJTreatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trialBr J Dermatol2012166114715321910714
  • ParkKKWuJJKooJA randomized, ‘head-to-head’ pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patientsJ Eur Acad Dermatol Venereol201327789990622702846
  • GordonKKormanNFrankelEEfficacy of etanercept in an integrated multistudy database of patients with psoriasisJ Am Acad Dermatol2006543 Suppl 2S101S11116488320
  • StroberBGottliebALeonardiCLevels of response of psoriasis patients with different baseline characteristics treated with etanerceptJ Am Acad Dermatol2006543 SupplAB220
  • Callis DuffinKYeungHTakeshitaJPatient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practiceBr J Dermatol2014170367268024266717
  • ZhangMBrennemanSKCarterCTPatient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasisPatient Prefer Adherence20158777784
  • YeungHWanJVan VoorheesASPatient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasisJ Am Acad Dermatol2013681647222846688
  • PaulCFHoVCMcGeownCRisk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort studyJ Invest Dermatol2003120221121612542524
  • PatelRVClarkLNLebwohlMWeinbergJMTreatments for psoriasis and the risk of malignancyJ Am Acad Dermatol20096061001101719344980
  • Di LerniaVAlbertiniGIs antitumour necrosis factor therapy combined with ultraviolet B phototherapy safe?Br J Dermatol201016251147114820128790
  • BlackRJGavinATPhotocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up dataBr J Dermatol2006154356656716445801
  • LeeEKooJBergerTUVB phototherapy and skin cancer risk: a review of the literatureInt J Dermatol200544535536015869531
  • HearnRMKerrACRahimKFFergusonJDaweRSIncidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapyBr J Dermatol2008159493193518834483